Siemens reveals R&D work on scanner that combines CT and PET technologies
Hybrid device adds BGO detectors to CT gantryExecutives with the nuclear medicine division of Siemens Medical Systems in Hoffman Estates, IL, this month confirmed rumors about the company's efforts to build a hybrid CT/PET scanner. While the
Hybrid device adds BGO detectors to CT gantry
Executives with the nuclear medicine division of Siemens Medical Systems in Hoffman Estates, IL, this month confirmed rumors about the company's efforts to build a hybrid CT/PET scanner. While the system is still in the early prototype phase, Siemens hopes that the unit could eventually result in a product capable of providing both anatomical and metabolic information in a single scan.
Siemens has long been rumored to be working on a hybrid CT/PET machine, but until this month's Society of Nuclear Medicine meeting in Toronto, the company had been tight-lipped about its work. At the SNM meeting, however, Siemens nuclear medicine division group vice president Barbara Franciose acknowledged the company's development of the device.
The first prototype CT/PET hybrid has been built and is installed at the University of Pittsburgh, Franciose said, where research on the system is being headed by Dr. David Townsend. The system consists of a Siemens Somatom Plus CT scanner, with a second ring of PET BGO detectors complementing the system's conventional ring of x-ray detectors. The system produced its first image the week before the SNM conference.
Siemens' goal in developing the scanner is to provide physicians with a more elegant way to merge anatomical detail, such as that collected with a CT scanner, with the metabolic information provided by PET. Image fusion techniques are already available that allow users to meld such data with software, but these methods require image registration and require patients to be scanned on two separate machines.
A hybrid system would make things easier for both patients and physicians and would also mesh with long-term trends in Siemens' medical imaging product development efforts, such as in oncology imaging, according to Franciose.
"If you envision imaging 10 years from now, there won't be separate machines. There will be combination machines," she said. "Siemens has strategically made a lot of investment in disease management, and we feel that this is a prototype that is on that same wavelength."
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
